Last Name

Theodore Stewart Gourdin

InstitutionMedical University of South Carolina
AddressP.O. Box MSC 635
Basic Science Building - 173 Ashley Ave.
vCardDownload vCard

    Collapse Overview 
    Collapse studies/trials
    Collapse keywords
    Cancer/Genitourinary, Women-s Health, Cancer, Drug Studies, Men-s Health

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gourdin T. Highlighting recent treatment advances in metastatic prostate cancer: expanding the treatment arsenal. Curr Opin Oncol. 2021 May 01; 33(3):252-256. PMID: 33818543.
      View in: PubMed
    2. Apolo AB, Ellerton JA, Infante JR, Agrawal M, Gordon MS, Aljumaily R, Gourdin T, Dirix L, Lee KW, Taylor MH, Schöffski P, Wang D, Ravaud A, Manitz J, Pennock G, Ruisi M, Gulley JL, Patel MR. Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis. J Immunother Cancer. 2020 10; 8(2). PMID: 33037118.
      View in: PubMed
    3. Gourdin T. Recent progress in treating advanced prostate cancer. Curr Opin Oncol. 2020 05; 32(3):210-215. PMID: 32209821.
      View in: PubMed
    4. McElwee JH, Gourdin TS, Mikoll J, Weeda E, Sion AM. Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials. J Oncol Pharm Pract. 2020 Jun; 26(4):861-865. PMID: 31566113.
      View in: PubMed
    5. Gourdin T. Optimization of therapies for men with advanced prostate cancer: a review of recent developments with a look toward the future. Curr Opin Oncol. 2019 05; 31(3):188-193. PMID: 30925537.
      View in: PubMed
    6. Sonpavde G, Agarwal N, Pond GR, Nagy RJ, Nussenzveig RH, Hahn AW, Sartor O, Gourdin TS, Nandagopal L, Ledet EM, Naik G, Armstrong AJ, Wang J, Bilen MA, Gupta S, Grivas P, Pal SK, Lanman RB, Talasaz A, Lilly MB. Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer. Cancer. 2019 05 01; 125(9):1459-1469. PMID: 30620391.
      View in: PubMed
    7. Shafqat H, Gourdin T, Sion A. Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy. Semin Oncol. 2018 06; 45(3):156-163. PMID: 30348532.
      View in: PubMed
    8. Gourdin T, Sonpavde G. Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer. Asian J Androl. 2018 May-Jun; 20(3):230-237. PMID: 29578115.
      View in: PubMed
    9. Gourdin T. Recent advances in the management of metastatic prostate cancer: optimizing use of existing therapies, while searching for novel interventions. Curr Opin Oncol. 2018 05; 30(3):159-164. PMID: 29553949.
      View in: PubMed
    10. Gourdin TS, Zou Y, Ning Y, Emadi A, Duong VH, Tidwell ML, Chen C, Rassool FV, Baer MR. High frequency of rare structural chromosome abnormalities at relapse of cytogenetically normal acute myeloid leukemia with FLT3 internal tandem duplication. Cancer Genet. 2014 Oct-Dec; 207(10-12):467-73. PMID: 25441683.
      View in: PubMed
    11. Bhatnagar B, Duong VH, Gourdin TS, Tidwell ML, Chen C, Ning Y, Emadi A, Sausville EA, Baer MR. Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy. Leuk Lymphoma. 2014 Jul; 55(7):1533-7. PMID: 24144313.
      View in: PubMed
    Gourdin's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description